Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M413971200 on January 18, 2005

J. Biol. Chem., Vol. 280, Issue 12, 11981-11986, March 25, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/12/11981    most recent
M413971200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilpatrick, Z. E.
Right arrow Articles by Kumar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilpatrick, Z. E.
Right arrow Articles by Kumar, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ecdysone-mediated Up-regulation of the Effector Caspase DRICE Is Required for Hormone-dependent Apoptosis in Drosophila Cells*

Zoé E. Kilpatrick{ddagger}, Dimitrios Cakouros, and Sharad Kumar§

From the Hanson Institute, Institute of Medical and Veterinary Science, PO Box 14, Rundle Mall, Adelaide, SA 5000, Australia

Received for publication, December 13, 2004 , and in revised form, January 10, 2005.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The Drosophila steroid hormone ecdysone mediates cell death during metamorphosis by regulating the transcription of a number of cell death genes. The apical caspase DRONC is known to be transcriptionally regulated by ecdysone during development. Here we demonstrate that ecdysone also regulates the transcription of DRICE, a major effector caspase and a downstream target for DRONC in the fly. Using RNA interference in an ecdysone-responsive Drosophila cell line, we show that drice up-regulation is essential for apoptosis induced by ecdysone. We also show that drice expression is specifically controlled by the ecdysone-regulated transcription factor BR-C. Combined with previous observations, our results indicate that transcriptional regulation of the components of the core apoptotic machinery plays a key role in hormone-regulated programmed cell death during Drosophila development.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Programmed cell death is necessary to delete superfluous cells in metazoans and to maintain homeostasis (reviewed in Refs. 1 and 2). The core cell death machinery, consisting of the BH3-only proteins, BCL-2 family, caspase adaptors, and caspases, is highly conserved and is present in all metazoan cells (reviewed in Refs. 3-6). As most components of the cell death machinery are present constitutively within a cell, it is widely believed that execution of apoptosis is primarily regulated post-transcriptionally, that is apoptotic signals somehow feed into and activate preexisting caspase machinery. However, recent data suggest that many components of the core apoptosis machinery, including some caspases, are transcriptionally regulated during cell death and that the levels of the prosurvival and proapoptotic factors in the cell may be crucial to activate the apoptotic program (reviewed in Ref. 4). Consistent with this, there is evidence that various signals such as cytotoxic insults, hormones, and growth factors regulate the activation of the death program by controlling the balance between prosurvival and proapoptotic proteins of the core cell death machinery (4). To understand cell death regulation, it is thus essential to understand the transcriptional control of apoptosis execution.

Steroid hormones are known to regulate cell survival and cell death in many tissues. Drosophila melanogaster is an ideal model system to study steroid hormone-regulated apoptosis as a single steroid hormone, 20-hydroxyecdysone, regulates cell death during development (reviewed in Refs. 5 and 7-9). Ecdysone binds to its heterodimeric EcR/Usp receptor and transcriptionally regulates a number of primary response genes. Waves of ecdysone, produced at various times during fly development, regulate molting, cell proliferation, differentiation, and death in a highly controlled manner (5, 7-9). During the transition of larva into pupa, an ecdysone pulse toward the end of the third larval instar stage signals puparium formation, followed by a second pulse ~12 h later, which initiates head eversion. During this process obsolete larval tissues, such as salivary glands and midgut, are deleted and replaced by adult tissues (5, 7-9). Cell death in the larval midgut begins in response to the late larval pulse of ecdysone while the salivary glands undergo removal around 15 h later in response to the second hormone pulse (5, 7-9).

Recent data suggest that EcR/Usp and ecdysone-induced transcription factors including {beta}FTZ-F1, BR-C, E74, E75, and E93 play a role in ecdysone-mediated cell death in the larval salivary gland and midgut (5, 8, 10-13). Studies, mostly with salivary glands, indicate that ecdysone controls the up-regulation of a number of proapoptotic genes such as rpr, hid, dark and dronc, and down-regulates the expression of death inhibitors such as diap1 and diap2 (14-16). Among the seven Drosophila caspases (17), ecdysone is well known to regulate dronc expression (18, 19). DRONC is a CED3/caspase-9-like apical caspase that is essential for several programmed cell death pathways in the fly (17, 18, 20). Our previous data with DRONC suggest that ecdysone-mediated up-regulation of dronc is an important regulator of hormone-dependent cell death in Drosophila cells (19). One of the downstream targets of DRONC is the effector caspase DRICE (17). As DRICE is the major caspase-3-like effector enzyme in Drosophila, we tested whether it is also regulated by ecdysone. We report here that drice up-regulation by ecdysone plays an important role in hormone-dependent cell death.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Ecdysone Treatment of Salivary Glands—Animals (W1118) were grown on bromphenol blue-supplemented food and staged by the gut clearance technique as previously described (13, 21). Late third instar larvae with empty guts were collected, dissected in Schneiders cell medium (Invitrogen), and incubated with or without 1 mM ecdysone (Sigma) for 1 h at 25 °C.

Cell Culture—Drosophila l(2)mbn cells, a kind gift from Dr. A. Dorn (Johannes Gutenburg University, Mainz, Germany) (22) were maintained as described previously (19). Cells, at 1 x 106/well, were seeded in six-well plates in triplicate or quadruplicate and allowed to recover for 3 days. Where necessary, ecdysone (10 µM) (Sigma) was added for the desired time. For RNA interference (RNAi)1 experiments, cells were treated with ecdysone until ~50% of control cells were apoptotic as the rate of l(2)mbn apoptosis varies between batches.

Apoptosis Detection—To assess apoptosis, cells were stained with 4'-6-diamidino-2-phenylindole (DAPI) fluorescent dye. Briefly, cells were fixed and stained with 1 µg/ml DAPI, 20% formaldehyde, and mounted 1:1 with 80% glycerol. Changes in nuclear morphology were observed by fluorescent microscopy and apoptosis (%) was calculated as the proportion of cells with condensed chromatin in a total count of at least 300 cells. Data were derived from three or four experiments.

Caspase Assays—Cell lysates were prepared by freeze thawing and clarified by centrifugation at 13,000 rpm for 5 min at 4 °C. Equal amounts of lysate were assayed for caspase activity using 100 µM VDVAD-amc and DEVD-amc substrates as described previously (23), and the release of amc was measured using a fluorometric plate reader (PerkinElmer Life Sciences) (excitation 385 nm, emission 460 nm).

RT-PCR Analysis—Total RNA was extracted from l(2)mbn cells using TRIzol reagent (Invitrogen) as per manufacturer's protocol. 1-5 µg of total RNA was used as a template for cDNA synthesis, in a 20-µl reaction with 500 ng of oligo(dT)18, using a Superscript II RNase H- Reverse Transcriptase kit (Invitrogen), according to manufacturer's protocol. Using 1.5 µl of 1:3 diluted cDNA template, PCR amplification was performed using appropriate primers in a 50-µl reaction employing 27-33 cycles. Drosophila rp49 was used as a control. Aliquots of PCR products (20 µl) were electrophoresed on 1.5-2% agarose gel for analysis.

Immunoblotting—Cell lysates were separated by 10% SDS-PAGE, transferred onto polyvinylidene difluoride membrane (Schleicher & Schuell) and blocked for 1 h in 5% skim milk (pH 7.5). Affinity-purified anti-DRONC (24) was used at a 1:300 dilution, and DRICE antibody (24) was used at a 1:500 dilution. Secondary alkaline phosphatase-conjugated anti-rabbit antibody (Amersham Biosciences) was used at 1:2000 dilution. Signals were detected using ECF system (Amersham Biosciences). A cytochrome c antibody was purchased from Pharmingen and used at a 1:2000 dilution as described (23, 24).

RNAi—Regions of cDNA for drice (nucleotides 451-968), dcp-1 (nucleotides 921-1303), dronc (nucleotides 781-1047), E74A (nucleotides 2929-3248), E74B (nucleotides 1367-1724), E75A (nucleotides 706-1060), E75B (nucleotides 893-1240), E93 (nucleotides 397-862), {beta}FTZ-F1 (nucleotides 39-530), and BR-C (nucleotides 392-1060) were PCR-amplified and cloned into pGEM-T Easy (Promega). Plasmids were linearized, and RNA was synthesized using T7 and SP6 Megascript kits (Ambion). Sense and antisense strands were annealed to generate dsRNA, and the quality of RNA was analyzed on a 2.2 M formaldehyde gel. dsRNA (~40 nM) was added to cells in 1 ml of serum-free medium and mixed vigorously as described previously (23-25). Cells were incubated for 1 h followed by the addition of 2 ml of medium supplemented with 15% fetal bovine serum. Cells were incubated at 27 °C for 3 days and then harvested for 0-h time points or treated with ecdysone for the required length of time.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
drice Is Up-regulated in Salivary Glands Treated with Ecdysone—It has previously been shown that ecdysone treatment of late second instar larvae salivary glands results in the up-regulation of dronc mRNA (18). Because the effector caspases are necessary for salivary gland death to occur (5, 8) we investigated whether the major downstream effector caspase DRICE was also regulated by ecdysone. To determine whether drice mRNA expression is induced by ecdysone, dissected salivary glands from staged late third instar larvae were treated with ecdysone. After a 1-h ecdysone treatment a dramatic increase in drice mRNA levels was observed, demonstrating that ecdysone can induce drice expression in larval salivary glands (Fig. 1A). Caspase assays performed with lysates from ecdysone-treated salivary glands showed elevated caspase activity (Fig. 1B). In particular we observed a 4.5-fold increase in activity on DEVD-amc, which is a substrate for DRICE. Consistent with this observation, DRICE protein levels were elevated in extracts from ecdysone-treated salivary glands (Fig. 1C). These findings suggest the involvement of DRICE in ecdysone-regulated salivary gland death and more importantly demonstrate that drice mRNA is up-regulated by ecdysone.



View larger version (37K):
[in this window]
[in a new window]
  		FIG. 1.
drice is up-regulated in salivary glands treated with ecdysone. Salivary glands were dissected from staged wild type late third instar larvae and were incubated for 1 h at 25 °C with 1 mM ecdysone or left untreated. A, to assess induction of drice, first strand cDNA was synthesized, and RT-PCR was performed using gene-specific oligos. rp49 levels were used as loading control. B, protein was prepared from homogenized tissues, and equal amounts were assayed for caspase activity on the substrates VDVAD-amc or DEVD-amc. Error bars represent S.D. from three experiments. C, protein lysates from untreated and ecdysone-treated salivary glands were immunoblotted with anti-DRICE and anti-cytochrome c antibodies. Cytochrome c (Cyt c) levels were used as loading control.

 
drice Is Induced by Ecdysone in l(2)mbn Cells—To further investigate the ecdysone-induction of drice transcription and dissect out its transcriptional regulation by various transcription factors we used the ecdysone-responsive Drosophila cell line l(2)mbn. We first analyzed ecdysone-mediated apoptosis by DAPI staining. As shown in Fig. 2A, apoptotic cells were identified by nuclear fragmentation. In the representative experiment shown in Fig. 2B, low levels of apoptosis were observed at 12- and 24-h post ecdysone treatment. From 36 h the number of cells undergoing apoptosis increased significantly, and by 48 h 70% of cells display condensed nuclei. Northern blot analysis indicated that l(2)mbn cells have low levels of drice transcript. Up-regulation of the drice transcript was evident 6 h after treatment and continued to increase with treatment time, being greatest at 48 h (Fig. 2C). Caspase activity on DEVD-amc and VDVAD-amc substrates was observed from 24 and 12 h, respectively, and subsequently increased with time (Fig. 2D). In addition, increased DRICE processing is observed around 36 h, and the accumulation of processed DRONC is evident at 12 h (Fig. 2E). The results with l(2)mbn cells confirm that drice is transcriptionally regulated by ecdysone treatment. In addition, our observations suggest that following ecdysone treatment of l(2)mbn cells, the increase in drice transcript levels correlates with increased DRICE and its processed form, DEVD-specific caspase activity, and apoptosis.



View larger version (54K):
[in this window]
[in a new window]
  		FIG. 2.
drice is regulated by ecdysone in l(2)mbn cells. Drosophila l(2)mbn cells were treated with 10 µM ecdysone for the indicated times. To determine apoptosis, chromatin condensation was analyzed by fluorescence microscopy and DAPI staining. A, at 0 h the cells are healthy and cycling. A cell division event is shown (*). Following 48 h of ecdysone treatment the characteristic nuclear fragmentation is evident. Arrowheads mark apoptotic cells. B, at least 300 cells were scored for each treatment time to calculate percent apoptosis. Error bars represent S.D. from three experiments. C, Northern blot analysis of drice mRNA using total RNA extracted from l(2)mbn cells after ecdysone treatment. rp49 expression was used as loading control. D, caspase activity in equal amounts of cell lysate was assessed using DEVD-amc () and VDVAD-amc ({circ}) substrates. E, Immunoblot analysis of precursor and processed (proc.) levels of DRICE and DRONC caspases. Cytochrome c (Cyt c) levels were used as loading control.

 
DRICE Is Essential for Execution of Apoptosis in l(2)mbn Cells following Ecdysone Treatment—We next wanted to determine the importance of DRICE in ecdysone-induced apoptosis of l(2)mbn cells. To do this we used RNAi to ablate gene function. Because DCP-1 is also an important effector caspase in Drosophila it was of interest to test whether there was compensation between the two key effector caspases, DRICE and DCP-1. We also tested whether knockdown of both drice and dcp-1 could prevent apoptosis of l(2)mbn cells following ecdysone treatment. As a comparison we silenced the expression of the initiator caspase DRONC, shown previously to be important in ecdysone-induced l(2)mbn death (19). The knockdown of drice, dcp-1, both drice and dcp-1, or dronc by RNAi was confirmed by RT-PCR analysis using total RNA prepared from ecdysone-treated cells (Fig. 3A). At a time when ~50% of control cells were undergoing apoptosis we were unable to detect significant levels of apoptosis in drice dsRNA-treated cells (Fig. 3B). The rate of ecdysone-induced apoptosis in dcp-1 knockdown cells was reduced to ~50% of controls (Fig. 3B) and was reduced to ~30% of controls in dronc knockdown cells (Fig. 3B). These results show that DRICE, DCP-1, and DRONC are all required for ecdysone to efficiently induce l(2)mbn apoptosis; however, ablation of drice had the most profound effect on ecdysone-mediated programmed cell death.



View larger version (38K):
[in this window]
[in a new window]
  		FIG. 3.
drice is required for ecdysone-induced l(2)mbn cell death. l(2)mbn cells were exposed to 40 nM dsRNA for drice, dcp-1, both drice and dcp-1, dronc, or a negative control for 3 days. Cells were then harvested or treated with 10 µM ecdysone. A, using gene-specific oligos, RT-PCR was used to confirm knockdown of drice, dcp-1, and dronc in ecdysone-treated samples. rp49 was used as loading control. B, percent apoptosis was assessed by chromatin condensation analysis of DAPI-stained cells. At least 300 cells were scored for each treatment. Error bars represent S.D. from three experiments. Graph is split to indicate data accumulated from two independent experiments.

 
DRICE Is Necessary for Maximal Ecdysone-induced Caspase Activity—Because DRICE function is essential for the efficient execution of apoptosis in ecdysone-treated l(2)mbn cells we wanted to establish its contribution to caspase activity. Caspase assays were performed with lysates using DEVD-amc and VDVAD-amc substrates (Fig. 4, A and B, respectively). In the absence of DRICE, lysates displayed basal levels of DEVDase activity. Ablation of dcp-1 resulted in ~25% activity of controls. When both drice and dcp-1 were silenced DEVDase activity was virtually abolished (Fig. 4A). Previous studies have established that DCP-1 is a substrate for DRICE (26) and that DEVD-amc is a substrate for both DRICE and DCP-1. Because drice knockdown completely abolished DEVDase activity, whereas dcp-1 RNAi lysates still display DEVDase activity, these findings imply a necessity for DRICE in DCP-1 activation. Ablating dronc results in DEVDase activity that is ~60% of controls (Fig. 4A). This is consistent with DRONC being an upstream activator of the effector caspases. When caspase assays were performed using a VDVAD-amc substrate, caspase activity following ecdysone treatment of drice or dcp-1 knockdown cells was only ~20% of controls (Fig. 4B). Silencing both drice and dcp-1 resulted in basal VDVADase activity (Fig. 4B). In the absence of dronc expression ~60% of control VDVADase activity was observed (Fig. 4B). Because VDVADase activity in part represents DRONC activity, these data suggest that DRICE and DCP-1 may affect DRONC activity. In addition, because activity on both DEVD-amc and VDVAD-amc substrates is still present in dronc knockdown cells, these data present evidence that DRICE activation may occur by means other than DRONC-mediated activation in l(2)mbn cells.



View larger version (34K):
[in this window]
[in a new window]
  		FIG. 4.
DRICE is required for maximal caspase activity in l(2)mbn cells following ecdysone treatment. l(2)mbn cells were exposed to 40 nM of dsRNA for drice, dcp-1, drice and dcp-1, dronc, or a negative control for 3 days. Cells were then harvested or treated with 10 µM ecdysone. Equal amounts of cell lysate were assayed for caspase activity using DEVD-amc (A) or VDVAD-amc (B) substrate. Activity was represented as a percentage of no RNAi + ecdysone and is expressed in relative fluorescence units (RFU). C, caspase expression and processing (proc.) was assessed by immunoblotting with anti-DRICE or anti-DRONC antibody. Cytochrome c (Cyt c) levels were used as loading control. Samples were derived from the experiments analyzed in Fig. 3.

 
Evidence for a Caspase Activation Loop in l(2)mbn Cells—To further characterize the effect of ablating drice gene function we analyzed protein expression and processing of DRICE and DRONC. In ecdysone-treated control cells we observe up-regulation of DRICE precursor and accumulation of its processed form (Fig. 4C, DRICE proc.). The ablation of either dcp-1 or dronc did not affect DRICE precursor levels; however, we see a reduced processing of DRICE. dronc RNAi had a more profound affect on DRICE processing than dcp-1 RNAi, thus both DRONC and DCP-1 may be capable of activating DRICE. As discussed previously, ecdysone treatment of l(2)mbn cells leads to an accumulation of processed DRONC (Fig. 4C, control lanes). We observe substantially reduced processed DRONC in the absence of DRICE (Fig. 4C). dcp-1 RNAi did not have any significant affect on processed DRONC levels. Because processed DRONC levels are significantly lower in drice-ablated ecdysone-treated cells, we propose that DRICE is required for amplification of DRONC processing following the initial activation of the upstream caspase.

Ecdysone-induced Factors E74A, E74B, E75A, E75B, E93, or {beta}FTZ-F1 Are Not Required for drice Up-regulation—Because we established drice up-regulation and the importance of DRICE in ecdysone-mediated apoptosis in l(2)mbn cells, we could now use this system to investigate the role of known ecdysone-induced transcription factors in drice transcription. We therefore carried out the RNAi ablation of several ecdysone-responsive transcription factors in l(2)mbn cells. The transcription factors E74A, E74B, E75A, E75B, E93, {beta}FTZ-F1, and BR-C have been identified as important regulators of ecdysone-mediated salivary gland death (14, 15, 27, 28). In Fig. 5A we show the effect of ablating E74A, E74B, E75A, or E75B on ecdysone-induced l(2)mbn apoptosis. Compared with controls, induction of apoptosis by ecdysone treatment was not significantly affected by silencing any of these transcription factors. When we silence E93, ecdysone-induced apoptosis was reduced by 35% compared with controls (Fig. 5B). {beta}FTZ-F1 RNAi did not affect apoptosis induction (Fig. 5B). Thus, of the transcription factors studied, only E93 was identified as being important for regulation of ecdysone-mediated apoptosis in l(2)mbn cells. We then analyzed drice transcription by RT-PCR. The ability of ecdysone to induce drice up-regulation was not affected by silencing E74A, E74B, E75A, E75B, E93, or {beta}FTZ-F1 (Fig. 5, C and D). Because E93 RNAi did not affect drice transcription, the rate of apoptosis in E93 knockdown cells is likely to be reduced as a result of reduced dronc expression, which has been previously reported (15).



View larger version (19K):
[in this window]
[in a new window]
  		FIG. 5.
E93 regulates ecdysone-mediated l(2)mbn apoptosis but does not affect drice transcription. RNAi was carried out for the ecdysone-responsive transcription factors E74A, E74B, E75A, E75B, E93, {beta}FTZ-F1, or a negative control. On day 3 cells were harvested or treated with 10 µM ecdysone until ~50% of control cells (no RNAi or control RNAi) were apoptotic. A and B, percent apoptosis was determined by DAPI analysis of chromatin condensation in at least 300 cells. Error bars represent S.D. from four (A) or three (B) experiments. C, RT-PCR analysis of drice expression to determine whether E93 RNAi regulates drice transcription. rp49 was used as loading control.

 
DEVDase Activity Is Not Directly Affected by the Ecdysone-responsive Transcription Factors E74A, E74B, E75A, E75B, E93, or {beta}FTZ-F1—Although drice transcription was not regulated by the ecdysone-responsive transcription factors E74A, E74B, E75A, E75B, E93, or {beta}FTZ-F1, it was of interest to establish whether there was any effect on caspase activity. Analysis of DEVDase activity shows that E74A, E74B, E75A, or E75B RNAi-treated cells achieve similar levels of DEVDase activity as controls (Fig. 6A). E93 RNAi resulted in DEVDase activity that was ~50% of control activity (Fig. 6B). Silencing {beta}FTZ-F1 had no significant effect on DEVDase activity (Fig. 6B). E74A, E74B, E75A, E75B, or {beta}FTZ-F1 ablation had no significant effect on VDVADase activity in l(2)mbn cells, whereas E93 RNAi showed significantly reduced levels of activity (Fig. 6, C and D). Thus ablation of E93, but not E74A, E74B, E75A, E75B, or {beta}FTZ-F1, leads to reduced caspase activity in ecdysone-treated l(2)mbn cells consistent with the effects we see on apoptosis induction. In the absence of E74A, E74B, E75A, E75B, or {beta}FTZ-F1, DRICE processing following ecdysone-induction of DRICE was relatively unchanged compared with controls (Fig. 6E). Although we see less processed DRICE in E93 RNAi lysates, induction of DRICE precursor is not significantly affected (Fig. 6E). Thus none of the transcription factors E74A, E74B, E75A, E75B, E93, or {beta}FTZ-F1 regulate ecdysone-induced drice transcription or expression of this effector caspase.



View larger version (48K):
[in this window]
[in a new window]
  		FIG. 6.
E93 knockdown reduced caspase activity but did not affect DRICE levels in ecdysone-treated l(2)mbn cells. We further analyzed the RNAi experiments carried out in Fig. 5. A and B, DEVD-amc was used as a substrate to analyze DRICE-like caspase activity. Error bars represent S.D.; RFU, relative fluorescence units. C and D, caspase activity was assessed using VDVAD-amc substrate. Error bars represent S.D. E, DRICE expression and processing (proc.) was analyzed by immunoblot analysis using anti-DRICE polyclonal antibody. Cytochrome c (Cyt c) levels were used as loading control.

 
BR-C Regulates Ecdysone-induced drice Transcription—The ecdysone-induced transcription factor BR-C plays a key role in salivary gland death and is a regulator of dronc transcription (14, 19). There are four isoforms of BR-C protein, Z1-Z4 (29). The Z2 isoform is constitutively present in l(2)mbn cells, and following ecdysone treatment the Z1, Z3, and Z4 isoforms are expressed (19). To test whether BR-C regulates ecdysone-induced drice transcription we carried out RNAi ablation of BR-C in l(2)mbn cells. BR-C RNAi significantly inhibited the rate of ecdysone-mediated apoptosis indicating that BR-C is an important regulator of ecdysone-induced apoptosis in l(2)mbn cells (Fig. 7A). Analysis of transcription by RT-PCR using total RNA shows that BR-C RNAi reduces ecdysone-induced transcription of drice (Fig. 7B). Activity on both DEVD-amc and VDVAD-amc substrates was reduced to ~30% of control activity in l(2)mbn cells treated with BR-C dsRNA (Fig. 7, C and D) correlating with the effects seen on apoptosis induction. Immunoblot analysis indicated that processing of both DRICE and DRONC was markedly reduced upon knockdown of BR-C (Fig. 7E). Additionally, ecdysone-induction of full-length DRICE and DRONC was significantly reduced (Fig. 7E). Our results therefore demonstrate that BR-C is required for ecdysone-mediated regulation of drice transcription.



View larger version (28K):
[in this window]
[in a new window]
  		FIG. 7.
BR-C regulates drice expression in ecdysone-treated l(2)mbn cells. Drosophila l(2)mbn cells were treated with 40 nM dsRNA for BR-C or a negative control. Cells were harvested on day 3 or treated with 10 µM ecdysone. A, apoptosis was calculated as the percentile of cells with condensed nuclei. At least 300 cells were scored for each treatment. Error bars represent S.D. from four experiments. B, RT-PCR was used to analyze drice expression and knockdown of BR-C. rp49 acts as loading control. DEVD-amc (C) and VDVAD-amc (D) substrates were used to assess caspase activity in equal amounts of lysate. E, immunoblot analysis of DRICE and DRONC expression and the accumulation of their processed bands (proc.). Cytochrome c (Cyt c) levels were used as loading control.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The data presented here demonstrate that drice expression is up-regulated in response to ecdysone in both larval salivary glands and Drosophila l(2)mbn cells. The observations are consistent with a large scale gene expression analysis during salivary gland cell death, which shows that drice, among many other genes, is up-regulated in dying salivary glands (30). When drice expression was ablated by RNAi, we observed low levels of caspase activity and a dramatic reduction in the rate of apoptosis following ecdysone treatment. In addition, our data suggest that DRICE is required for DRONC processing in ecdysone-treated l(2)mbn cells. Recent studies have shown that effector caspase activation in some tissues may occur in the absence of DRONC (13, 18). Data in this paper complement these findings and supports the observation that some DRICE activation may occur in the absence of DRONC.

Expression of the cell death genes rpr, hid, crq, dark, and dronc in salivary glands and midgut has been shown to be regulated by ecdysone-responsive transcription factors BR-C and E93 (14-16). The knockdown of BR-C in l(2)mbn cells reduced ecdysone-induced drice transcription and resulted in reduced DRICE expression, thus demonstrating that BR-C regulates drice transcription in l(2)mbn cells. E93 knockdown did not affect drice regulation following ecdysone treatment of l(2)mbn cells. As E93 regulates dronc expression (15, 21, 31), the decrease in apoptosis levels that we observed is likely to be a result of reduced dronc transcription and protein expression. Although BR-C and E93 are required in both salivary gland and midgut apoptosis, their functions differ between the tissues. For example, dronc expression is regulated in salivary glands by both BR-C and E93 but only by E93 in the midgut (15, 33). It would be interesting to test whether like dronc, BR-C regulation of drice is tissue-specific. The competence factor {beta}FTZ-F1 is needed for the precise developmental re-expression of transcription factors including BR-C and E93 (32). We investigated its involvement in ecdysone-induced l(2)mbn apoptosis. Our findings demonstrate no clear role for {beta}FTZ-F1 in regulating the apoptosis of l(2)mbn cells. We speculate that in l(2)mbn cells, {beta}FTZ-F1 is not required, because l(2)mbn cells do not undergo developmental transitions.

Studies in this paper suggest that ecdysone-regulated DRICE is an essential effector of apoptosis execution in l(2)mbn cells. Based on the data presented here, we propose a model for DRICE-mediated amplification of the caspase cascade in ecdysone-treated cells (Fig. 8). Given that drice mutants are currently unavailable, specific ablation of this caspase in salivary glands and midgut may be required to further investigate the role of DRICE in ecdysone-induced programmed cell death in vivo.



View larger version (11K):
[in this window]
[in a new window]
  		FIG. 8.
A model for amplification of the caspase cascade in ecdysone-treated l(2)mbn cells. In l(2)mbn cells treated with ecdysone dronc and drice are up-regulated, resulting in the activation of these caspases. Initial activation of DRONC probably occurs autocatalytically. Active DRONC then mediates DRICE processing and activation. We proposed that as active DRICE accumulates there is positive feedback (shown by broken lines) and DRICE processes DRONC. The processing of DRONC by DRICE further potentiates activation of the effector caspases, enabling efficient execution of apoptosis. The caspase cascade is further amplified by a positive feedback loop between DRICE and DCP-1.

 

   FOOTNOTES
 
* This work was supported by the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} Supported by an Australian Postgraduate Award. Back

§ To whom correspondence should be addressed. Fax: 61-8-8222-3139; E-mail: sharad.kumar{at}imvs.sa.gov.au.

1 The abbreviations used are: RNAi, RNA interference; dsRNA, double-stranded RNA; DAPI, 4'-6-diamidino-2-phenylindole; amc, amino-methylcoumarin; RT-PCR, reverse transcription PCR. Back


   ACKNOWLEDGMENTS
 
We thank Tasman Daish for technical help and Augustus Dorn for l(2)mbn cells.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Lockshin, R. A., and Zakeri, Z. (2001) Nat. Rev. Mol. Cell. Biol. 2, 545-550[CrossRef][Medline] [Order article via Infotrieve]
  2. Zakeri, Z., and Lockshin, R. A. (2002) J. Immunol. Methods 265, 3-20[CrossRef][Medline] [Order article via Infotrieve]
  3. Adams, J. M. (2003) Genes Dev. 17, 2481-2495[Free Full Text]
  4. Kumar, S., and Cakouros, D. (2004) Trends Biochem. Sci. 29, 193-199[CrossRef][Medline] [Order article via Infotrieve]
  5. Baehrecke, E. H. (2002) Nat. Rev. Mol. Cell. Biol. 3, 779-787[CrossRef][Medline] [Order article via Infotrieve]
  6. Danial, N. N., and Korsmeyer, S. J. (2004) Cell 116, 205-219[CrossRef][Medline] [Order article via Infotrieve]
  7. Thummel, C. S. (1996) Trends Genet. 12, 306-310[CrossRef][Medline] [Order article via Infotrieve]
  8. Baehrecke, E. H. (2000) Cell Death Differ. 7, 1057-1062[CrossRef][Medline] [Order article via Infotrieve]
  9. Truman, J. W., and Riddiford, L. M. (2002) Annu. Rev. Entomol. 47, 467-500[CrossRef][Medline] [Order article via Infotrieve]
  10. Jiang, C., Baehrecke, E. H., and Thummel, C. S. (1997) Development 124, 4673-4683[Abstract]
  11. Quinn, L. M., Dorstyn, L., Mills, K., Colussi, P. A., Chen, P., Coombe, M., Abrams, J., Kumar, S., and Richardson, H. (2000) J. Biol. Chem. 275, 40416-40424[Abstract/Free Full Text]
  12. Chew, S. K., Akdemir, F., Chen, P., Lu, W. J., Mills, K., Daish, T., Kumar, S., Rodriguez, A., and Abrams, J. M. (2004) Dev. Cell 7, 897-907[CrossRef][Medline] [Order article via Infotrieve]
  13. Daish, T. J., Mills, K., and Kumar, S. (2004) Dev. Cell 7, 909-915[CrossRef][Medline] [Order article via Infotrieve]
  14. Jiang, C., Lamblin, A. F., Steller, H., and Thummel, C. S. (2000) Mol. Cell 5, 445-455[CrossRef][Medline] [Order article via Infotrieve]
  15. Lee, C., Cooksey, B., and Baehrecke, E. (2002) Dev. Biol. 250, 101-111[CrossRef][Medline] [Order article via Infotrieve]
  16. Lee, C. Y., and Baehrecke, E. H. (2000) Cell Res. 10, 193-204[CrossRef][Medline] [Order article via Infotrieve]
  17. Kumar, S., and Doumanis, J. (2000) Cell Death Differ. 7, 1039-1044[CrossRef][Medline] [Order article via Infotrieve]
  18. Dorstyn, L., Colussi, P. A., Quinn, L. M., Richardson, H., and Kumar, S. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4307-4312[Abstract/Free Full Text]
  19. Cakouros, D., Daish, T., Martin, D., Baehrecke, E. H., and Kumar, S. (2002) J. Cell Biol. 157, 985-995[Abstract/Free Full Text]
  20. Richardson, H., and Kumar, S. (2002) J. Immunol. Methods 265, 21-38[CrossRef][Medline] [Order article via Infotrieve]
  21. Daish, T. J., Cakouros, D., and Kumar, S. (2003) Cell Death Differ. 10, 1348-1356[CrossRef][Medline] [Order article via Infotrieve]
  22. Ress, C., Holtmann, M., Maas, U., Sofsky, J., and Dorn, A. (2000) Tissue Cell 32, 464-477[CrossRef][Medline] [Order article via Infotrieve]
  23. Dorstyn, L., Mills, K., Lazebnik, Y., and Kumar, S. (2004) J. Cell Biol. 167, 405-410[Abstract/Free Full Text]
  24. Dorstyn, L., Read, S., Cakouros, D., Huh, J. R., Hay, B. A., and Kumar, S. (2002) J. Cell Biol. 156, 1089-1098[Abstract/Free Full Text]
  25. Cakouros, D., Daish, T. J., and Kumar, S. (2004) J. Cell Biol. 165, 631-640[Abstract/Free Full Text]
  26. Fraser, A. G., McCarthy, N. J., and Evan, G. I. (1997) EMBO J. 16, 6192-6199[CrossRef][Medline] [Order article via Infotrieve]
  27. Lee, C. Y., and Baehrecke, E. H. (2001) Development 128, 1443-1455[Abstract]
  28. Martin, D. N., and Baehrecke, E. H. (2004) Development 131, 275-284[Abstract/Free Full Text]
  29. DiBello, P. R., Withers, D. A., Bayer, C. A., Fristrom, J. W., and Guild, G. M. (1991) Genetics 129, 385-397[Abstract]
  30. Lee, C. Y., Clough, E. A., Yellon, P., Teslovich, T. M., Stephan, D. A., and Baehrecke, E. H. (2003) Curr. Biol. 13, 350-357[CrossRef][Medline] [Order article via Infotrieve]
  31. Lee, C. Y., Wendel, D. P., Reid, P., Lam, G., Thummel, C. S., and Baehrecke, E. H. (2000) Mol. Cell 6, 433-443[CrossRef][Medline] [Order article via Infotrieve]
  32. Lee, C. Y., Simon, C. R., Woodard, C. T., and Baehrecke, E. H. (2002) Dev. Biol. 252, 138-148[CrossRef][Medline] [Order article via Infotrieve]
  33. Broadus, J., McCabe, J. R., Endrizzi, B., Thummel, C. S., and Woodard, C. T. (1999) Mol. Cell 3, 143-149[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DevelopmentHome page
Y. Liu, Z. Sheng, H. Liu, D. Wen, Q. He, S. Wang, W. Shao, R.-J. Jiang, S. An, Y. Sun, et al.
Juvenile hormone counteracts the bHLH-PAS transcription factors MET and GCE to prevent caspase-dependent programmed cell death in Drosophila
Development, June 15, 2009; 136(12): 2015 - 2025.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
D. A. Primrose, S. Chaudhry, A. G. D. Johnson, A. Hrdlicka, A. Schindler, D. Tran, and E. Foley
Interactions of DNR1 with the apoptotic machinery of Drosophila melanogaster
J. Cell Sci., April 1, 2007; 120(7): 1189 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
C. W. Maurer, M. Chiorazzi, and S. Shaham
Timing of the onset of a developmental cell death is controlled by transcriptional induction of the C. elegans ced-3 caspase-encoding gene
Development, April 1, 2007; 134(7): 1357 - 1368.
[Abstract] [Full Text] [PDF]

Home page
 Integr. Comp. Biol.Home page
B. Santelices and J. Alvarado
Applying the concept of metamorphosis to the crustose-to-erect thallus transition of macroalgae
Integr. Comp. Biol., December 1, 2006; 46(6): 713 - 718.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/12/11981    most recent
M413971200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilpatrick, Z. E.
Right arrow Articles by Kumar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilpatrick, Z. E.
Right arrow Articles by Kumar, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement